0
0
In a significant boost for India’s healthcare infrastructure, 11 listed and two major unlisted private hospital chains are set to invest over ₹30,000 crore to add approximately 14,500 new beds across metropolitan, Tier-II, and Tier-III cities by the end of fiscal year 2027, according to a recent ICRA report.
The credit rating agency projects that this ambitious expansion will increase the hospital sector’s total bed capacity by nearly 26 percent compared to levels at the close of FY2025. The initiative is expected to focus strongly on Tier-II cities, aiming to improve healthcare access beyond major urban centers.
ICRA’s industry outlook anticipates that bed occupancy rates will stabilize between 62–64 percent in the coming years. Meanwhile, the average revenue per occupied bed (ARPOB) is expected to grow at an annual rate of 6–8 percent, continuing the 7 percent year-on-year growth observed in FY25. This growth is attributed to factors such as annual price revisions to address cost inflation and the adoption of advanced technologies—like robotic surgeries—which are helping hospitals achieve higher realizations per patient.
The sector’s financial outlook remains robust, with hospital operating profit margins projected at 22–24 percent, thanks to ongoing cost optimization strategies and digitization initiatives. Return on capital employed (RoCE) for FY26 is forecast between 13–15 percent. Despite capital investments being partly funded by debt, ICRA considers industry debt metrics healthy, with the Debt/OPBDITA ratio expected to rise to 2.4–2.6x in FY26 from 2.1x in March 2025, supported by absolute growth in operating profit.
ICRA also notes a trend toward industry consolidation, as many hospital chains pursue inorganic growth opportunities, fueling heightened interest from institutional investors due to the sector’s strong performance outlook.
“In FY26, the ARPOB growth for the industry is expected to remain between 6-8 percent, in line with the 7 percent YoY expansion seen in FY25 and annual price revisions by companies to offset cost inflation, in addition to technological advancements (such as robotic surgeries) augmenting high realisations for the hospitals,” said Mythri Macherla, Vice President & Sector Head, ICRA.
Disclaimer: The information above is based on projections and data from ICRA as presented in a news release dated August 1, 2025. Actual investment figures, expansion timelines, and financial performance may vary due to market conditions, regulatory changes, or other external factors. The article is for informational purposes only and should not be construed as investment advice.
